首页 > 最新文献

The Lancet regional health. Southeast Asia最新文献

英文 中文
Strengthening WHO's South-East Asia Regional Office: from crisis to opportunity? 加强世卫组织东南亚区域办事处:从危机到机遇?
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100684
Swarup Sarkar , Diah Saminarsih , J.V.R. Prasada Rao , Kent Buse
{"title":"Strengthening WHO's South-East Asia Regional Office: from crisis to opportunity?","authors":"Swarup Sarkar , Diah Saminarsih , J.V.R. Prasada Rao , Kent Buse","doi":"10.1016/j.lansea.2025.100684","DOIUrl":"10.1016/j.lansea.2025.100684","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100684"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The domino effect: projecting the effects of US funding cuts to health aid in the global south 多米诺骨牌效应:预测美国削减对南半球国家医疗援助资金的影响
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100700
Rechel Shrisunder, Dwight Figueiredo
{"title":"The domino effect: projecting the effects of US funding cuts to health aid in the global south","authors":"Rechel Shrisunder, Dwight Figueiredo","doi":"10.1016/j.lansea.2025.100700","DOIUrl":"10.1016/j.lansea.2025.100700","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100700"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145624637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive primary health care for cost-effective scale-up of depression screening in India: an economic modelling study 综合初级卫生保健在印度经济有效地扩大抑郁症筛查:一项经济模型研究
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100701
Neha Purohit , Shubh Mohan Singh , Girish N. Rao , Kathirvel Soundappan , Atul Kotwal , Shankar Prinja

Background

The Government of India envisions integrating population-based depression screening within the framework of comprehensive primary health care. This study assesses the economic impact and cost-utility of implementing universal depression screening for different age groups (≥30 years and ≥20 years) compared to the current practice of opportunistic diagnosis and management of symptomatic patients.

Methods

A hybrid model comprising of a decision tree and Markov model was developed for economic evaluation. The input parameters were acquired through comprehensive literature search, stakeholder consultations, analysis of the data from National Mental Health Survey, and the National Sample Survey, besides primary data collected from 259 patients for quality of life. The analysis was performed from both abridged societal (consideration of direct costs) and societal perspective (consideration of direct as well as indirect costs). In line with Indian economic evaluation standards, a screening strategy was deemed cost-effective if its incremental cost-utility ratio (ICUR) was below the per capita gross domestic product (GDP) threshold of ₹1,71,498 ($2182).

Findings

The gain in QALYs per person from universal screening ranged from 0·0273 (0·0265–0·0281) to 0·0295 (0·0287–0·0303), depending on the target age group. The program is expected to generate net savings of ₹291 billion ($3·7 billion) to ₹482 billion ($6·1 billion), equivalent to 0·19% to 0·32% of GDP. Furthermore, the ICURs were below the threshold, with ≥20 years aged cohort screening (₹43,995, $620) being more cost-effective than the screening in ≥30 years aged population (₹48,746, $560) from the abridged societal perspective. However, the program ceases to yield positive net health benefits if the sensitivity of the PHQ-2 decreases to 26%, or if the combined sensitivity of the sequential PHQ-2 and PHQ-9 approach falls below 35%. The intervention is likely to result in cost savings if at least 60% of patients seeking treatment after screening use public health facilities.

Interpretation

Integrating depression screening and management into the government primary healthcare system provides substantial public health and economic benefits, supporting the case for a PHC-oriented health system. Expanding coverage to individuals aged 20 years and above, along with ensuring high diagnostic accuracy through quality training and supportive supervision, will be key to sustaining and maximizing the programme's impact.

Funding

The study was supported by funding from the Department of Health Research, Ministry of Health and Family Welfare, Government of India
印度政府设想将基于人口的抑郁症筛查纳入综合初级卫生保健的框架。本研究评估了对不同年龄组(≥30岁和≥20岁)实施普遍抑郁症筛查的经济影响和成本效益,并与目前对有症状患者进行机会性诊断和管理的做法进行了比较。方法建立由决策树模型和马尔可夫模型组成的混合模型进行经济评价。输入参数是通过综合文献检索、利益相关者咨询、全国心理健康调查和全国抽样调查数据分析以及从259名患者中收集的生活质量的原始数据获得的。分析是从社会(考虑直接成本)和社会(考虑直接和间接成本)两方面进行的。根据印度经济评估标准,如果其增量成本效用比(ICUR)低于人均国内生产总值(GDP)阈值1,71,498卢比(2182美元),则认为筛查策略具有成本效益。根据目标年龄组的不同,普遍筛查的人均QALYs的增加范围为0.0273(0.0265 - 0.0281)至0.0295(0.0287 - 0.0303)。该计划预计将产生2910亿卢比(37亿美元)至4820亿卢比(61亿美元)的净储蓄,相当于GDP的0.19%至0.32%。此外,ICURs低于阈值,从简化的社会角度来看,≥20岁队列筛查(43,995卢比,620美元)比≥30岁人群筛查(48,746卢比,560美元)更具成本效益。然而,如果PHQ-2的敏感性降至26%,或者顺序PHQ-2和PHQ-9方法的综合敏感性降至35%以下,该计划就不再产生积极的净健康效益。如果至少60%的筛查后寻求治疗的患者使用公共卫生设施,干预措施可能会节省费用。将抑郁症筛查和管理纳入政府初级卫生保健系统提供了巨大的公共卫生和经济效益,支持以初级卫生保健为导向的卫生系统。将覆盖范围扩大到20岁及以上的个人,同时通过高质量的培训和支持性监督确保诊断的高准确性,将是维持和最大限度地发挥该规划影响的关键。该研究得到了印度政府卫生和家庭福利部卫生研究司的资助
{"title":"Comprehensive primary health care for cost-effective scale-up of depression screening in India: an economic modelling study","authors":"Neha Purohit ,&nbsp;Shubh Mohan Singh ,&nbsp;Girish N. Rao ,&nbsp;Kathirvel Soundappan ,&nbsp;Atul Kotwal ,&nbsp;Shankar Prinja","doi":"10.1016/j.lansea.2025.100701","DOIUrl":"10.1016/j.lansea.2025.100701","url":null,"abstract":"<div><h3>Background</h3><div>The Government of India envisions integrating population-based depression screening within the framework of comprehensive primary health care. This study assesses the economic impact and cost-utility of implementing universal depression screening for different age groups (≥30 years and ≥20 years) compared to the current practice of opportunistic diagnosis and management of symptomatic patients.</div></div><div><h3>Methods</h3><div>A hybrid model comprising of a decision tree and Markov model was developed for economic evaluation. The input parameters were acquired through comprehensive literature search, stakeholder consultations, analysis of the data from National Mental Health Survey, and the National Sample Survey, besides primary data collected from 259 patients for quality of life. The analysis was performed from both abridged societal (consideration of direct costs) and societal perspective (consideration of direct as well as indirect costs). In line with Indian economic evaluation standards, a screening strategy was deemed cost-effective if its incremental cost-utility ratio (ICUR) was below the per capita gross domestic product (GDP) threshold of ₹1,71,498 ($2182).</div></div><div><h3>Findings</h3><div>The gain in QALYs per person from universal screening ranged from 0·0273 (0·0265–0·0281) to 0·0295 (0·0287–0·0303), depending on the target age group. The program is expected to generate net savings of ₹291 billion ($3·7 billion) to ₹482 billion ($6·1 billion), equivalent to 0·19% to 0·32% of GDP. Furthermore, the ICURs were below the threshold, with ≥20 years aged cohort screening (₹43,995, $620) being more cost-effective than the screening in ≥30 years aged population (₹48,746, $560) from the abridged societal perspective. However, the program ceases to yield positive net health benefits if the sensitivity of the PHQ-2 decreases to 26%, or if the combined sensitivity of the sequential PHQ-2 and PHQ-9 approach falls below 35%. The intervention is likely to result in cost savings if at least 60% of patients seeking treatment after screening use public health facilities.</div></div><div><h3>Interpretation</h3><div>Integrating depression screening and management into the government primary healthcare system provides substantial public health and economic benefits, supporting the case for a PHC-oriented health system. Expanding coverage to individuals aged 20 years and above, along with ensuring high diagnostic accuracy through quality training and supportive supervision, will be key to sustaining and maximizing the programme's impact.</div></div><div><h3>Funding</h3><div>The study was supported by funding from the <span>Department of Health Research</span>, <span>Ministry of Health and Family Welfare</span>, <span>Government of India</span></div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100701"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145694091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer-specific thresholds of treatment initiation delay and assessment of their confounding variables: authors' reply 癌症特异性治疗起始延迟阈值及其混杂变量评估:作者回复
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100675
Jyoti Dixit , Nidhi Gupta , Pritam Halder , Shankar Prinja
{"title":"Cancer-specific thresholds of treatment initiation delay and assessment of their confounding variables: authors' reply","authors":"Jyoti Dixit ,&nbsp;Nidhi Gupta ,&nbsp;Pritam Halder ,&nbsp;Shankar Prinja","doi":"10.1016/j.lansea.2025.100675","DOIUrl":"10.1016/j.lansea.2025.100675","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100675"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145786493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concerns on construct validity and contamination in the Lay-CARE study — authors’ reply Lay-CARE研究中对结构效度和污染的关注——作者的回复
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100655
Tawanchai Jirapramukpitak , Suttha Supanya
{"title":"Concerns on construct validity and contamination in the Lay-CARE study — authors’ reply","authors":"Tawanchai Jirapramukpitak ,&nbsp;Suttha Supanya","doi":"10.1016/j.lansea.2025.100655","DOIUrl":"10.1016/j.lansea.2025.100655","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100655"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality among hospitalized children with melioidosis in Thailand: a retrospective national database analysis (2015–2023) 泰国住院类鼻疽患儿死亡率:2015-2023年回顾性国家数据库分析
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100707
Phanthila Sitthikarnkha , Sirapoom Niamsanit , Leelawadee Techasatian , Suchaorn Saengnipanthkul , Kaewjai Thepsuthammarat , Pope Kosararaksa , Nattakarn Tantawarak , Punnathorn Auaboonkanok , Phenphitcha Pornprasitsakul , Rattapon Uppala

Background

Pediatric melioidosis remains under-characterized nationally in Thailand, hindering triage and critical-care planning. We quantified epidemiology, complications, and mortality correlates among hospitalized children.

Methods

Retrospective analysis of Thailand's National Health Security Office database from January 2015 to Dec 2023, including patients <18 years with principal melioidosis. Incidence and case-fatality rate were calculated. Mortality-related clinical characteristics were compared using descriptive statistics.

Findings

Among 5044 admissions, 58.3% were male and 80.5% from the Northeast; annual incidence ranged 3.7–5.8 per 100,000, peaking in 2023. Median length of hospital stay was 11 days. Lower respiratory tract infection was the commonest localized focus (17.6%), followed by septic shock (2.9%). Organ dysfunction consisted of acute respiratory failure 3.2%, acute renal failure 2.3%, and disseminated intravascular coagulation (DIC) 1.7%. There were 2.3% required intubation with mechanical ventilation >96 h, and 2.2% needed renal replacement therapy. Overall, 84 children died (1.7%); deaths clustered in tertiary hospitals (71.4%). Mortality was markedly higher among children with septic shock, lower respiratory tract infection, and acute respiratory failure compared with children without these complications.

Interpretation

National data identify a Northeast-weighted pediatric burden and a high-risk trajectory from pneumonia to acute respiratory failure, shock, and DIC. Embedding pediatric sepsis bundles with early melioidosis-active therapy and seasonal pediatric intensive care unit (PICU) surge/transfer protocols, may shorten time-to-treatment and reduce deaths substantially and equitably.

Funding

This study was supported by the Fundamental Fund, Khon Kaen University, Thailand.
背景:在泰国,儿童类鼻疽病在全国范围内的特征仍然不足,这阻碍了分诊和重症护理计划。我们量化了住院儿童的流行病学、并发症和死亡率相关因素。方法回顾性分析泰国国家卫生安全办公室2015年1月至2023年12月的数据库,包括18岁的主要类鼻瘤病患者。计算发病率和病死率。死亡率相关临床特征采用描述性统计进行比较。结果:在5044名录取学生中,58.3%为男性,80.5%来自东北地区;年发病率为每10万人3.7-5.8人,2023年达到高峰。住院时间中位数为11天。下呼吸道感染是最常见的局部病灶(17.6%),其次是感染性休克(2.9%)。器官功能障碍包括急性呼吸衰竭3.2%,急性肾功能衰竭2.3%,弥散性血管内凝血(DIC) 1.7%。2.3%需要插管机械通气96小时,2.2%需要肾脏替代治疗。总体而言,84名儿童死亡(1.7%);死亡集中在三级医院(71.4%)。感染性休克、下呼吸道感染和急性呼吸衰竭患儿的死亡率明显高于无这些并发症的患儿。国家数据确定了东北加权儿科负担和从肺炎到急性呼吸衰竭、休克和DIC的高风险轨迹。将儿童败血症包与早期类鼻疽积极治疗和季节性儿科重症监护病房(PICU)激增/转移方案相结合,可以缩短治疗时间,并大大减少死亡。本研究由泰国孔敬大学基础基金资助。
{"title":"Mortality among hospitalized children with melioidosis in Thailand: a retrospective national database analysis (2015–2023)","authors":"Phanthila Sitthikarnkha ,&nbsp;Sirapoom Niamsanit ,&nbsp;Leelawadee Techasatian ,&nbsp;Suchaorn Saengnipanthkul ,&nbsp;Kaewjai Thepsuthammarat ,&nbsp;Pope Kosararaksa ,&nbsp;Nattakarn Tantawarak ,&nbsp;Punnathorn Auaboonkanok ,&nbsp;Phenphitcha Pornprasitsakul ,&nbsp;Rattapon Uppala","doi":"10.1016/j.lansea.2025.100707","DOIUrl":"10.1016/j.lansea.2025.100707","url":null,"abstract":"<div><h3>Background</h3><div>Pediatric melioidosis remains under-characterized nationally in Thailand, hindering triage and critical-care planning. We quantified epidemiology, complications, and mortality correlates among hospitalized children.</div></div><div><h3>Methods</h3><div>Retrospective analysis of Thailand's National Health Security Office database from January 2015 to Dec 2023, including patients &lt;18 years with principal melioidosis. Incidence and case-fatality rate were calculated. Mortality-related clinical characteristics were compared using descriptive statistics.</div></div><div><h3>Findings</h3><div>Among 5044 admissions, 58.3% were male and 80.5% from the Northeast; annual incidence ranged 3.7–5.8 per 100,000, peaking in 2023. Median length of hospital stay was 11 days. Lower respiratory tract infection was the commonest localized focus (17.6%), followed by septic shock (2.9%). Organ dysfunction consisted of acute respiratory failure 3.2%, acute renal failure 2.3%, and disseminated intravascular coagulation (DIC) 1.7%. There were 2.3% required intubation with mechanical ventilation &gt;96 h, and 2.2% needed renal replacement therapy. Overall, 84 children died (1.7%); deaths clustered in tertiary hospitals (71.4%). Mortality was markedly higher among children with septic shock, lower respiratory tract infection, and acute respiratory failure compared with children without these complications.</div></div><div><h3>Interpretation</h3><div>National data identify a Northeast-weighted pediatric burden and a high-risk trajectory from pneumonia to acute respiratory failure, shock, and DIC. Embedding pediatric sepsis bundles with early melioidosis-active therapy and seasonal pediatric intensive care unit (PICU) surge/transfer protocols, may shorten time-to-treatment and reduce deaths substantially and equitably.</div></div><div><h3>Funding</h3><div>This study was supported by the <span>Fundamental Fund</span>, <span>Khon Kaen University</span>, Thailand.</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100707"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological issue in a dental neuromelioidosis outbreak investigation 一起牙齿类神经瘤病暴发调查的方法学问题
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100658
Bijayini Behera , Prasanta Raghab Mohapatra
{"title":"Methodological issue in a dental neuromelioidosis outbreak investigation","authors":"Bijayini Behera ,&nbsp;Prasanta Raghab Mohapatra","doi":"10.1016/j.lansea.2025.100658","DOIUrl":"10.1016/j.lansea.2025.100658","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100658"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Lancet Regional Health—Southeast Asia: 2025 year in review 《柳叶刀-区域卫生-东南亚:2025年回顾》
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100704
Shalini Garg, Bhavani Nivetha, Apoorva Dharmendra
{"title":"The Lancet Regional Health—Southeast Asia: 2025 year in review","authors":"Shalini Garg,&nbsp;Bhavani Nivetha,&nbsp;Apoorva Dharmendra","doi":"10.1016/j.lansea.2025.100704","DOIUrl":"10.1016/j.lansea.2025.100704","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100704"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indonesia leaves SEARO: what it means for regional health and WHO 印度尼西亚离开SEARO:它对区域卫生和世卫组织意味着什么
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100660
Habib Benzian , Manu Raj Mathur
{"title":"Indonesia leaves SEARO: what it means for regional health and WHO","authors":"Habib Benzian ,&nbsp;Manu Raj Mathur","doi":"10.1016/j.lansea.2025.100660","DOIUrl":"10.1016/j.lansea.2025.100660","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100660"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tiny lives, big failures: India's drug regulation crisis 微小的生命,巨大的失败:印度的药品监管危机
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lansea.2025.100705
The Lancet Regional Health – Southeast Asia
{"title":"Tiny lives, big failures: India's drug regulation crisis","authors":"The Lancet Regional Health – Southeast Asia","doi":"10.1016/j.lansea.2025.100705","DOIUrl":"10.1016/j.lansea.2025.100705","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"43 ","pages":"Article 100705"},"PeriodicalIF":6.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet regional health. Southeast Asia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1